PSG — PharmaSGP Holding SE Balance Sheet
0.000.00%
- €282.97m
- €315.12m
- €101.10m
- 98
- 50
- 83
- 94
Annual balance sheet for PharmaSGP Holding SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 88.5 | 8 | 20.8 | 33.9 | 40.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 11.4 | 11.1 | 7.23 | 8.3 | 9.42 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 102 | 22.4 | 32.5 | 51.5 | 62.8 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.254 | 0.753 | 0.541 | 1.57 | 1.18 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 104 | 24.9 | 115 | 129 | 131 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7.94 | 13 | 92.7 | 22.7 | 24.6 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 8.16 | 13.4 | 93.1 | 98 | 91.5 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 95.6 | 11.5 | 22.2 | 31.1 | 39.8 |
Total Liabilities & Shareholders' Equity | 104 | 24.9 | 115 | 129 | 131 |
Total Common Shares Outstanding |